Cargando…

FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms

Tumour invasion and metastasis is the most common cause of death from cancer. For epithelial cells to invade surrounding tissues and metastasise, an epithelial-mesenchymal transition (EMT) is required. We have demonstrated that FGFR1 expression is increased in bladder cancer and that activation of F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomlinson, Darren C., Baxter, Euan W., Loadman, Paul M., Hull, Mark A., Knowles, Margaret A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373505/ https://www.ncbi.nlm.nih.gov/pubmed/22701738 http://dx.doi.org/10.1371/journal.pone.0038972

Ejemplares similares

FGFR-2 and Epithelial–Mesenchymal Transition in Endometrial Cancer
por: Adamczyk-Gruszka, Olga, et al.
Publicado: (2022)

Molecular genetic analysis of FGFR1 signalling reveals distinct roles of MAPK and PLCγ1 activation for self-renewal of adult neural stem cells
por: Ma, Dengke K, et al.
Publicado: (2009)

Interplay between FGFR2b‐induced autophagy and phagocytosis: role of PLCγ‐mediated signalling
por: Nanni, Monica, et al.
Publicado: (2017)

Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition
por: Ranieri, Danilo, et al.
Publicado: (2015)

LMNA Reduced Acquired Resistance to Erlotinib in NSCLC by Reversing the Epithelial–Mesenchymal Transition via the FGFR/MAPK/c-fos Signaling Pathway
por: Hu, Chunsheng, et al.
Publicado: (2022)

Time-resolved FRET reports FGFR1 dimerization and formation of a complex with its effector PLCγ1
por: Perdios, Louis, et al.
Publicado: (2016)

Astilbe chinensis Modulates Platelet Function via Impaired MAPK and PLCγ2 Expression
por: Jeon, Bo-Ra, et al.
Publicado: (2018)

Two major gate-keepers in the self-renewal of neural stem cells: Erk1/2 and PLCγ1 in FGFR signaling
por: Lee, Jin-A, et al.
Publicado: (2009)

FGFR4 Role in Epithelial-Mesenchymal Transition and Its Therapeutic Value in Colorectal Cancer
por: Peláez-García, Alberto, et al.
Publicado: (2013)

Role of PKCε in the epithelial-mesenchymal transition induced by FGFR2 isoform switch
por: Ranieri, Danilo, et al.
Publicado: (2020)

Maelstrom promotes tumor metastasis through regulation of FGFR4 and epithelial-mesenchymal transition in epithelial ovarian cancer
por: He, Wei-Peng, et al.
Publicado: (2022)

Amarogentin, a Secoiridoid Glycoside, Abrogates Platelet Activation through PLCγ2-PKC and MAPK Pathways
por: Yen, Ting-Lin, et al.
Publicado: (2014)

FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition
por: Brown, Wells S., et al.
Publicado: (2016)

Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells
por: Grygielewicz, Paulina, et al.
Publicado: (2014)

FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation
por: Foth, Mona, et al.
Publicado: (2018)

Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways
por: Lien, Li-Ming, et al.
Publicado: (2017)

Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation
por: Peiris, Malalage N., et al.
Publicado: (2022)

Cigarette smoke induced urocystic epithelial mesenchymal transition via MAPK pathways
por: Yu, Dexin, et al.
Publicado: (2017)

Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma
por: Chen, Lu, et al.
Publicado: (2019)

The FGFR1 inhibitor PD173074 induces mesenchymal–epithelial transition through the transcription factor AP-1
por: Nguyen, P T, et al.
Publicado: (2013)

FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition
por: Cho, Sang Hee, et al.
Publicado: (2017)

Inhibitory effects of msFGFR2c on the epithelial-to-mesenchymal transition of AE2 cells in pulmonary fibrosis
por: Jieming, Guo, et al.
Publicado: (2020)

Involvement of Src kinases and PLCγ2 in clot retraction
por: Suzuki-Inoue, Katsue, et al.
Publicado: (2007)

The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration
por: Jackson, Jacob T., et al.
Publicado: (2021)

Cbl Suppresses B Cell Receptor–Mediated Phospholipase C (Plc)-γ2 Activation by Regulating B Cell Linker Protein–Plc-γ2 Binding
por: Yasuda, Tomoharu, et al.
Publicado: (2000)

Oncogenic FGFR3 gene fusions in bladder cancer
por: Williams, Sarah V., et al.
Publicado: (2013)

Effects of PPARγ ligands on TGF-β1-induced epithelial-mesenchymal transition in alveolar epithelial cells
por: Tan, Xiahui, et al.
Publicado: (2010)

PLC-γ2 is essential for formation and maintenance of memory B cells
por: Hikida, Masaki, et al.
Publicado: (2009)

Conformational switches that control the TEC kinase – PLCγ signaling axis
por: Lowe, Jacques, et al.
Publicado: (2022)

PLCγ1 promotes phase separation of T cell signaling components
por: Zeng, Longhui, et al.
Publicado: (2021)

The Aberrant Expression of the Mesenchymal Variant of FGFR2 in the Epithelial Context Inhibits Autophagy
por: Nanni, Monica, et al.
Publicado: (2019)

Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways
por: Ma, Wenqiong, et al.
Publicado: (2023)

Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway
por: Qin, Ge, et al.
Publicado: (2015)

Curcumin Suppresses Intestinal Fibrosis by Inhibition of PPARγ-Mediated Epithelial-Mesenchymal Transition
por: Xu, Su, et al.
Publicado: (2017)

MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma
por: Setlai, Botle Precious, et al.
Publicado: (2022)

Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker
por: Chong, Yosep, et al.
Publicado: (2020)

Structural basis for the activation of PLC-γ isozymes by phosphorylation and cancer-associated mutations
por: Hajicek, Nicole, et al.
Publicado: (2019)

Periostin promotes epithelial-mesenchymal transition via the MAPK/miR-381 axis in lung cancer
por: Hu, Wei-Wei, et al.
Publicado: (2017)

Unconventional MAPK-GSK-3β Pathway Behind Atypical Epithelial-Mesenchymal Transition In Hepatocellular Carcinoma
por: Parveen, Sana, et al.
Publicado: (2017)

Fruitflow inhibits platelet function by suppressing Akt/GSK3β, Syk/PLCγ2 and p38 MAPK phosphorylation in collagen-stimulated platelets
por: Chen, Huilian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_avsqmqeobphao09gof57hfuvge